GlobalIPNews

Sign Up
|
Login
|

13:03:08 Mon 08 Jun 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Tianjin University

(35)

Shanghai Jiao Tong Univer

(34)

(16)

(14)

Eli Lilly and Company

(12)

Hoffmann La Roche

(12)

Genzyme Corporation

(7)

Jiangsu Hengrui Pharmaceu

(7)

Boehringer Ingelheim Inte

(6)

China Pharmaceutical Univ

(6)

Kumquat Biosciences

(6)

Ruijin Hospital Shanghai

(6)

Tianjin University of Sci

(6)

(5)

(5)

Meilan Hangzhou Pharmaceu

(5)

(5)

Zhejiang Yulong Pharmaceu

(5)

Bristol Myers Squibb

(4)

Fundacion Instituto De In

(4)

Guangdong Fapon Biopharma

(4)

Guangdong Power Grid; Sha

(4)

Harbin Medical University

(4)

Jewim Pharmaceutical (Sha

(4)

Jiangsu Sino Biopharma Co

(4)

Otsuka Pharmaceutical

(4)

Spirit Jinyu Biological P

(4)

State Grid Shanghai Munic

(4)

Suzhou Ribo Life Science

(4)

Topfond Pharma Co Ltd

(4)

Zhejiang University

(4)

Adlai Nortye Biopharma

(3)

Anomed Singapore Pte Ltd;

(3)

(3)

Cisen Pharmaceutical Co L

(3)

Guoke Ningbo Life And Hea

(3)

Hangzhou Zhongmei Huadong

(3)

Hebei Longhai Pharmaceuti

(3)

Hubei Gedian Humanwell Ph

(3)

Janssen Pharmaceutica

(3)

Jiangsu 707 Natural Pharm

(3)

Jiangsu Dongkang Biomedic

(3)

Nuclear Power Institute o

(3)

Qilu Pharmaceutical

(3)

Regeneron Pharmaceuticals

(3)

Shandong Chuangxin Pharma

(3)

Shandong Institute of Med

(3)

Shandong Linuo Pharmaceut

(3)

Shenzhen Rhegen Biotechno

(3)

Shenzhen Salubris Pharmac

(3)

Sunshine Lake Pharma

(3)

Tianjin University of Com

(3)

TreeFrog Therapeutics

(3)

Wuxi Fortune Pharmaceutic

(3)

Zhejiang Nuode Pharmaceut

(3)

ADARx Pharmaceuticals

(2)

Anhui University of Chine

(2)

Ascletis Pharma China Co

(2)

Atossa Therapeutics

(2)

Beijing Hospital

(2)

Beijing Sun Novo Pharmace

(2)

Boehringer Ingelheim Int

(2)

Borea Therapeutics S R L

(2)

Changchun Genescience Pha

(2)

Changchun University of T

(2)

Chengdu Paiweisi Smart Me

(2)

Chia Tai Tianqing Pharmac

(2)

China Academy of Chinese

(2)

Chongqing Guochengtang Ph

(2)

Chongqing Xinongdakexin A

(2)

Circum Medtech Pharma

(2)

Cls Therapeutics Llc

(2)

Crinetics Pharmaceuticals

(2)

Davis Andrew Peter

(2)

Dominic Schiller [gb]; Ge

(2)

Duke Street Bio Ltd

(2)

ENSEM Therapeutics

(2)

Fuzhou Neptunus Fuyao Pha

(2)

(2)

(2)

(2)

GlaxoSmithKline Biologica

(2)

Graviton Bioscience Bv

(2)

Guangdong Lanyu Biotechno

(2)

Gwangju Inst Of Science A

(2)

Haisco Pharmaceutical Gro

(2)

Hangzhou Fst Pharmaceutic

(2)

Heilongjiang University o

(2)

Hoffmann La Roche [ch]; R

(2)

Hubei Shuangxing Pharmace

(2)

Inflamed Pharma Gmbh

(2)

Insilico Medicine

(2)

Institute Military Medici

(2)

Jiangnan University

(2)

Jiangsu Aidea Pharmaceuti

(2)

Jiangsu Hengrui Pharmaceu

(2)

Jiangsu Zhongbang Pharmac

(2)

Jiangxi Jinding Pharmaceu

(2)

Jiangxi Tianxin Pharmaceu

(2)

Jiaozuo Furuitang Pharmac

(2)

Jiuzhou Pharmaceutical Ha

(2)

Koerber Pharma Inspection

(2)

Korea Inst Of Science And

(2)

Korea University Research

(2)

Lanzhou University

(2)

Merck Sharp & Dohme

(2)

(2)

Nanjing Children\'s Hospi

(2)

Nanjing Leizheng Pharmace

(2)

Nanjing Normal University

(2)

Nanjing Puruida Pharmaceu

(2)

(2)

Peking University First H

(2)

Porton Pharma Solutions

(2)

Qualicaps Co Ltd

(2)

Renji Hospital Shanghai J

(2)

Revolution Medicines

(2)

Ribocure Pharmaceuticals

(2)

Roche Diagnostics Gmbh [d

(2)

Shaanxi Kanghe Li Feng Bi

(2)

Shandong Sirui Pharmaceut

(2)

Shanghai Argo Biopharmace

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Tongjin Stem Cel

(2)

Shanghai Yingli Pharmaceu

(2)

Shenyang Pharmaceutical U

(2)

Shenzhen Tegede Medical T

(2)

Shijiazhuang Gerui Pharma

(2)

(2)

Sichuan Kelun-Biotech Bio

(2)

Sichuan Neo Green Pharmac

(2)

Simcere Zaiming Pharmaceu

(2)

Solve Therapeutics

(2)

Soochow University

(2)

Sun Yat Sen University Sh

(2)

Sun Yat-sen University

(2)

Takeda Pharmaceuticals

(2)

Tekang Pharmaceutical Gro

(2)

Tianjin University of Tec

(2)

Tianjin University of Tra

(2)

Tianjin University; Yulin

(2)

(2)

Univ Ewha Ind Collaborati

(2)

Veradermics Incorporated

(2)

Vertex Pharmaceuticals

(2)

Wuhan Createrna Science a

(2)

Wuhan Guanggu Zhongyuan P

(2)

Wuxi Jiyu Shanhe Pharmace

(2)

Wuxi Origene Bio Tech Co

(2)

Xi\'an International Medi

(2)

Xinhua Hospital affiliate

(2)

Xinjiang Western Saiao Bi

(2)

Xizang Haisco Pharmaceuti

(2)

Zhejiang University; Jian

(2)

ADS Therapeutics

(1)

Aarhus University

(1)

Abbisko Pharmaceuticals C

(1)

Ablexa Pharmaceuticals In

(1)

Ablynx Nv [be]; Sanofi

(1)

Academia Sinica

(1)

Acrotech Biopharma Inc

(1)

Acurastem Incorporated

(1)

Acurx Pharmaceuticals Inc

(1)

Adcentrx Therapeutics Inc

(1)

Adienne Pharma & Biotech

(1)

Adlai Nortye Biopharma; A

(1)

Affiliated Hospital Xuzho

(1)

Affiliated Hospital of Na

(1)

Affiliated Hospital of So

(1)

Affiliated Hospital of Ya

(1)

Agency for Science, Techn

(1)

(1)

Aitemei Suzhou Pharmaceut

(1)

Aivo Biosciences Inc

(1)

Aiweituo Jiangsu Pharmace

(1)

Aiweituo Jiangsu Pharmace

(1)

Akava Therapeutics Inc [u

(1)

(1)

(1)

Alkermes Pharma Ireland

(1)

Altmedical Co Ltd [kr]; D

(1)

Ambio Life Sciences Inc

(1)

Amgen Inc [us]; Revolutio

(1)

Anavex Life Sciences

(1)

(1)

Anglii Tianjin Biotechnol

(1)

Anhui Anke Yuliangqing Ph

(1)

Anhui Double Crane Pharma

(1)

Anhui Institute of Inform

(1)

Anhui Jiuxin Pharmaceutic

(1)

Anhui Longyibaicao Biolog

(1)

Anhui Medical University

(1)

Anhui Nuoerkang Pharmaceu

(1)

Anhui Ruiqi Pharmaceutica

(1)

Anhui University; Institu

(1)

Anhui Xinshiji Pharmaceut

(1)

Anhui Yipuke Medical Tech

(1)

Anlong Biopharmaceutical

(1)

Aodh Lifesciences Private

(1)

Apellis Pharmaceuticals

(1)

Apogee Therapeutics Inc

(1)

Applied Res Using Omic Sc

(1)

Apstem Therapeutics Inc

(1)

Arromax Pharmatech Co Ltd

(1)

Arvinas Operations

(1)

Ascentage Pharma Suzhou C

(1)

Ascentawits Pharmaceutica

(1)

Ascletis Pharma China Co

(1)

Asr Technologies Co Ltd;

(1)

Astelza Therapeutics Inc

(1)

(1)

Atai Therapeutics

(1)

Atreya Innovations Pvt Lt

(1)

(1)

Auspex Pharmaceuticals Ll

(1)

Austar Pharmaceutical Equ

(1)

(1)

(1)

Bacto Pharma Ltd

(1)

Bai Yao Zhi Da Beijing Na

(1)

Baisite Pharmaceutical Gu

(1)

Bashanhong Beijing Pharma

(1)

Bayer Animal Health

(1)

Beijing Academy of Scienc

(1)

Beijing Continent Pharmac

(1)

Beijing Double Crane Phar

(1)

Beijing Gengshi Co Ltd

(1)

Beijing Hengcheng Huiren

(1)

Beijing Inst Of Tradition

(1)

Beijing Kangchuanglian Bi

(1)

Beijing Northland Biotech

(1)

Beijing Proteome Res Cent

(1)

Beijing Tcmages Pharmaceu

(1)

Beijing Tianheng Pharmace

(1)

Beijing University of Che

(1)

Beijing University of Chi

(1)

Beijing Xianhan Guoke Bio

(1)

Beijing Xuanjingrui Pharm

(1)

Beijing Yunpeng Pengcheng

(1)

Beijing Zaiqing Biotechno

(1)

Bencaofangtang Traditiona

(1)

Bened Biomedical Co Ltd

(1)

Bide Pharmatech Co Ltd

(1)

Big Health Res Institute

(1)

Big Health Res Institute

(1)

Bijie Traditional Chinese

(1)

(1)

Biocells Beijing Biotechn

(1)

Biogen Ma Inc [us]; Ginkg

(1)

Biogend Therapeutics Co L

(1)

Biomedical Lab S R L

(1)

Bisirna Therapeutics Pte

(1)

Bluebable Pharmaceutical

(1)

Bluerock Therapeutics Lp

(1)

Boehringer Ingelheim Anim

(1)

Boehringer Ingelheim Int

(1)

Boehringer Ingelheim Inte

(1)

Boehringer Ingelheim Vetm

(1)

Bormioli Pharma S P A

(1)

Brain Check Medical Llc

(1)

Butura Christian

(1)

CCCC-FHDI Engineering; Ti

(1)

CSPC Zhongqi Pharmaceutic

(1)

(1)

California Inst Of Techno

(1)

Cambridge Allergy Ltd

(1)

Canwell Biotech Ltd

(1)

Capital University of Med

(1)

Capsugel Belgium Nv

(1)

Cardurion Pharmaceuticals

(1)

Carmot Therapeutics Inc [

(1)

Cd Suzhou Biopharma Co Lt

(1)

Cedars Sinai Medical Cent

(1)

Cell Therapy And Tech S A

(1)

Cella Therapeutics Llc

(1)

Cemm Forschungszentrum Fu

(1)

Central South University

(1)

Central South University;

(1)

Centre For Chinese Herbal

(1)

Centrexion Therapeutics

(1)

Cerevel Therapeutics Llc

(1)

Cf Pharmatech Inc

(1)

Cg Pharmaceuticals Inc

(1)

(1)

Changchun Lanjiang Pharma

(1)

Changchun Sinobiomaterial

(1)

Changchun University of C

(1)

Changshan Conjuchem Biolo

(1)

Changzhou Bohiv Pharmaceu

(1)

Changzhou Hongmeng Bio Te

(1)

Changzhou Jiade Pharmaceu

(1)

Changzhou Pharmaceutical

(1)

Changzhou Shenghui Pharma

(1)

Changzhou Sunlight Pharm

(1)

Changzhou University

(1)

Chemical Research Institu

(1)

(1)

Chengdu Chipscreen Pharma

(1)

Chengdu Greenpure Biophar

(1)

Chengdu Jiuzhitang Jindin

(1)

Chengdu Medical College

(1)

Chengdu New Radiomedicine

(1)

Chengdu Organic Chemistry

(1)

Chengdu Puth Pharmaceutic

(1)

Chengdu Shibeikang Biomed

(1)

Chengdu Shuode Pharmaceut

(1)

Chengdu University of Tra

(1)

Chengdu Yangtian Wanying

(1)

Chiesi Farmaceutici

(1)

China Academy of Art

(1)

China Chemical & Pharmace

(1)

China Nat Offshore Oil Co

(1)

China Resources Sanjiu Me

(1)

China Union Chempharma Su

(1)

Chong Kun Dang Pharmaceut

(1)

Chongqing Kerui Pharmaceu

(1)

Chongqing Medical Univers

(1)

Chongqing Pharscin Pharma

(1)

Chongqing Research Instit

(1)

Chongqing Traditional Chi

(1)

Chongqing University

(1)

Chongqing University of E

(1)

Chongqing University of P

(1)

Chongqing University of S

(1)

Chongqing University of T

(1)

Chongqing University; Uni

(1)

Chongqing Xiukang Traditi

(1)

Chongqing Yaogu Pharmaceu

(1)

Chugai Pharmaceutical

(1)

(1)

City University of Hong K

(1)

Clearside Biomedical Inc

(1)

Convalife Pharmaceuticals

(1)

Convelo Therapeutics Inc

(1)

Cool Pharmaceuticals Dev

(1)

Cornovus Pharmaceuticals

(1)

Cosa Group Gmbh

(1)

Council of Scientific & I

(1)

Cross Walker Therapeutics

(1)

Cyclacel Pharmaceuticals

(1)

Daan Biotherapeutics Co L

(1)

Daiichi Sankyo Healthcare

(1)

Dalian Polytechnic Univer

(1)

Dalian Shuangpeng Pharmac

(1)

Dalian University

(1)

Dalian University of Tech

(1)

Dalian Zhen Ao Pharmaceut

(1)

(1)

Dana Farber Cancer Inst I

(1)

Dangshan County Peoples H

(1)

(1)

Demarest Stephen [us]; Ka

(1)

Design Therapeutics

(1)

Dewpoint Therapeutics

(1)

Dexing City Chinese Medic

(1)

Dexon Pharmaceuticals Inc

(1)

Dezhou Jinghua Pharmaceut

(1)

Dezhou Kinsana Pharmaceut

(1)

Diagopreutic Private Ltd

(1)

Dongfang Hospital Beijing

(1)

Dongying Pingming Pharmac

(1)

Droplet Genomics Uab

(1)

Duality Biologics Suzhou

(1)

Duality Biologics Suzhou

(1)

(1)

East China Normal Univers

(1)

East China University of

(1)

Efx Medical Tech Pty Ltd

(1)

Electric Power Science Re

(1)

Eleven Therapeutics

(1)

Eli Lilly And Co

(1)

Enanta Pharmaceuticals

(1)

Endo Ventures Ltd [ie]; E

(1)

Eonvelab Co Ltd

(1)

Epirium Bio Inc

(1)

Epitech Group S P A

(1)

Erchu of China Railway Tu

(1)

(1)

Eye Hospital of China Aca

(1)

Fasikl Incorporated [us];

(1)

(1)

(1)

Firat Univ Rektorlugu

(1)

Firmenich & Cie

(1)

First Affiliated Hospital

(1)

(1)

Foghorn Therapeutics

(1)

Fortune Res & Development

(1)

Foshan Power Supply Burea

(1)

Fourth Hospital of Hebei

(1)

Fresenius Kabi Oncology L

(1)

Fujian Leephick Pharmaceu

(1)

(1)

Fuzhou Zhixin Future Elec

(1)

GM Global Tech Operations

(1)

Gan & Lee Pharmaceuticals

(1)

Gansu Pharmaceutical Grou

(1)

(1)

Genentech Inc [us]; Hoffm

(1)

General Biological Anhui

(1)

Gesynta Pharma Ab

(1)

Gilead Sciences

(1)

GlaxoSmithKline Intellect

(1)

Glaxosmithkline Biologica

(1)

Gluetacs Therapeutics Sha

(1)

(1)

Groovy Medicine Hangzhou

(1)

Guangdong HEC Pharmaceuti

(1)

Guangdong Haikaipu New Ph

(1)

Guangdong Huanan Pharmacy

(1)

Guangdong Muhou Pharmaceu

(1)

Guangdong Pharmaceutical

(1)

Guangdong Provincial Labo

(1)

Guangdong Provincial Peop

(1)

Guangdong Raynovent Biote

(1)

Guangdong University of T

(1)

Guangdong Yifang Pharmace

(1)

Guangdong Ziying Kangyan

(1)

Guanghan Hospital of Trad

(1)

Guangxi Inst Chinese Medi

(1)

Guangxi Pingguo Runfeng C

(1)

Guangxi University of Chi

(1)

Guangxi Zhuangyuan Pharma

(1)

Guangzhou Congen Pharmate

(1)

Guangzhou Daguang Pharmac

(1)

Guangzhou Hutong Youwu Bi

(1)

Guangzhou Jintai Life Tec

(1)

Guangzhou Junmu Biotechno

(1)

Guangzhou Medical Univers

(1)

Guangzhou Medical Univers

(1)

Guangzhou Medical Univers

(1)

Guangzhou Medical Univers

(1)

Guangzhou National Labora

(1)

Guangzhou National Labora

(1)

Guangzhou Novaken Pharm C

(1)

Guangzhou Trojan Pharmate

(1)

Guangzhou University of C

(1)

Guangzhou Vocational and

(1)

Guangzhou Zhongda Furui M

(1)

Guhan Traditional Chinese

(1)

Guizhou Beijixing Pharmac

(1)

Guizhou Natural Product R

(1)

Guizhou Nursing Vocationa

(1)

Guizhou Ruihe Pharmaceuti

(1)

Guizhou Weikang Zifan Pha

(1)

(1)

Guorui Guangzhou Biologic

(1)

Guosheng Zhiku Culture De

(1)

(1)

Hadasit Medical Res Servi

(1)

Hainan Hualon Pharmaceuti

(1)

Hainan Jiajiakang Medical

(1)

Hainan University

(1)

Hamada Katsuyuki

(1)

Hangzhou City Xiaoshan Di

(1)

Hangzhou Cixing Tech Co L

(1)

Hangzhou Dinghe Intellige

(1)

Hangzhou Enhe Biotechnolo

(1)

Hangzhou Innogate Pharma

(1)

Hangzhou Shengzhitang Bio

(1)

Hangzhou Tiankang Chuangj

(1)

Hangzhou Tongjuntang Biol

(1)

Hangzhou Yiwan Intelligen

(1)

Hangzhou Zhongmei Huadong

(1)

Hanmi Fine Chemical

(1)

Hanmi Pharmaceutical

(1)

Harbin Pharmaceutical Gro

(1)

Health Ai Holdings Ltd

(1)

Hebei Kaiwei Hengcheng Ph

(1)

Hebei Kangbo Pharmaceutic

(1)

Hebei Reproductive Health

(1)

Hefei Institute Technolog

(1)

Hefei Jingke Biotechnolog

(1)

Hefei Normal University

(1)

Heilongjiang Sengong Trad

(1)

Heilongjiang University

(1)

Heilongjiang University;

(1)

Helmholz Zentrum Muenchen

(1)

Henan Academy of Medical

(1)

Henan Nuomei Pharmaceutic

(1)

Henan Provincial Eye Hosp

(1)

Henan Shuanghe Huali Phar

(1)

Henan Univ Of Medicine

(1)

Henan University of Chine

(1)

Henan Xiangyu Medical Equ

(1)

Herun Ruikang Shanghai Bi

(1)

Highfield Biopharmaceutic

(1)

Hoffmann La Roche [ch]; H

(1)

Hoffmann La Roche [ch]; H

(1)

Hoffmann-La Roche

(1)

Huachuan Pharmaceutical C

(1)

Huangshan Bonsun Pharmace

(1)

Huashen Zhiyao Biotechnol

(1)

Huaxia Chenghuang Beijing

(1)

Huazhong Pharmaceutical C

(1)

Hubei Bio Pharmaceutical

(1)

Hubei Bio Pharmaceutical

(1)

Hubei Changjiang Ruiyi Ph

(1)

Hubei Chuwei Pharmaceutic

(1)

Hubei Gedian Humanwell Ph

(1)

Hubei Gongtong Pharmaceut

(1)

Hubei Guangren Medicament

(1)

Hubei Hongyuan Pharmaceut

(1)

Hubei Shizhen Laboratory

(1)

Hubei University of Techn

(1)

Hubei Wudang Animal Pharm

(1)

Hubei Yixin Tianan Medica

(1)

Hubei Yuanhao Biotechnolo

(1)

Hudong-Zhonghua Shipbuild

(1)

Huizhou Huasheng Biotechn

(1)

Hunan Aikesong Health Man

(1)

Hunan Asidikang Pharmaceu

(1)

Hunan Huize Bio Pharmaceu

(1)

Hunan Juxiangtang Biologi

(1)

Hunan Meibai Biological P

(1)

Hunan Nonferrous Metals V

(1)

Hunan Province Xiangzhong

(1)

Hunan Runxing Pharmaceuti

(1)

Hunan Space Folding Inter

(1)

Hunan University of Chine

(1)

Hunan Yifang Tianjiang Ph

(1)

I Care You Biotech Co Ltd

(1)

I P I Inworth Pharma Inc

(1)

Ibio Inc [us]; Astralbio

(1)

Il Dong Pharmaceutical

(1)

Infinitus China Co Ltd

(1)

Inito Health Inc

(1)

Inmedical Therapeutics S

(1)

Inner Mongolia Ringpu Dad

(1)

Innovative Molecules Gmbh

(1)

Innovent Biologics Suzhou

(1)

Inst Basic Science [kr];

(1)

Inst Med Biotechnology Ca

(1)

Institute of Botany, Jian

(1)

Institute of Medicinal Pl

(1)

Intas Pharmaceuticals

(1)

Integrated DNA Technologi

(1)

Intellia Therapeutics

(1)

Intra-Cellular Therapies

(1)

Ipsen Biopharmaceuticals

(1)

Janssen Biotech

(1)

Jazz Pharmaceuticals Irel

(1)

Jazz Pharmaceuticals Rese

(1)

Jds Therapeutics Llc

(1)

Jem Therapeutics Inc

(1)

Ji Can Artificial Intelli

(1)

Jiang Chenghong

(1)

Jiangsu Agri Animal Husba

(1)

Jiangsu Chenxing Pharmace

(1)

Jiangsu Hansyn Pharmaceut

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Hi Stone Pharmace

(1)

Jiangsu Huajing Molecular

(1)

Jiangsu Jiaerke Pharmaceu

(1)

Jiangsu Jingchan Pharmace

(1)

Jiangsu Kunli Biological

(1)

Jiangsu Lianhuan Pharmace

(1)

Jiangsu Nhwa Pharmaceutic

(1)

Jiangsu Provincial Xuzhou

(1)

Jiangsu Qunxin Powder Tec

(1)

Jiangsu Runan Pharmaceuti

(1)

Jiangsu Simcere Medical D

(1)

Jiangsu Targetpharma Labo

(1)

Jiangsu University

(1)

Jiangsu Wangao Pharmaceut

(1)

Jiangsu Weiyao Informatio

(1)

Jiangsu Yahong Medicine S

(1)

Jiangsu Yahong Meditech C

(1)

Jiangxi Brother Pharmaceu

(1)

Jiangxi Fangzhu Pharmaceu

(1)

Jiangxi Fuerxin Pharmaceu

(1)

Jiangxi Lushan Pharmaceut

(1)

Jiangxi Shimei Pharmaceut

(1)

Jiangxi Universe Pharmace

(1)

Jiangxi Woran Pharmaceuti

(1)

Jiangxi Yuanbang Pharmace

(1)

Jiangxian Dev Zone Hongru

(1)

Jiangzhong Pharmaceutical

(1)

Jianmin Group Yekaitai Si

(1)

Jianmin Pharmaceutical Gr

(1)

Jianyang People\'s Hospit

(1)

Jiaxing Andicon Biotech C

(1)

Jiaxing Baimei Jihua Phar

(1)

Jilin Mufeng Pharmaceutic

(1)

Jilin University

(1)

Jilin Xiuzheng Pharmaceut

(1)

Jinan Kehui Pharmaceutica

(1)

Jinan University

(1)

Jining Shengtai Pharmaceu

(1)

Jiuzhou Pharmaceutical Ha

(1)

Just Medical Equipment (T

(1)

Kane Therapeutics Inc

(1)

Kangbaida (Sichuan) Biote

(1)

Kindeva Drug Delivery L P

(1)

Kinhoo Pharmaceutical Co

(1)

(1)

Kolinpharma S P A

(1)

Korea Res Inst Bioscience

(1)

Kunming Keen Pharmaceutic

(1)

Kunming University of Sci

(1)

Kunshan Biogreen Tech Co

(1)

(1)

Lanzhou Biotechnology Dev

(1)

Lanzhou Inst Of Husbandry

(1)

Lanzhou University Second

(1)

Leaderna Therapeutics Ltd

(1)

Legacy Healthcare (Switze

(1)

Leiyunshang Pharmaceutica

(1)

Leland Stanford Junior Un

(1)

Lepu Biopharma Co Ltd

(1)

Les Laboratoires Servier

(1)

Levena Suzhou Biopharma C

(1)

(1)

Liaoning Inspection Exami

(1)

Liaoning Jiayu Tech Co Lt

(1)

Liaoning Wohua Kangchen P

(1)

Liaoning Youmi Future Tec

(1)

Lifemine Therapeutics Inc

(1)

Lilly Co Eli [us]; Nimbus

(1)

(1)

Lingyuan Pharmaceutical C

(1)

Linnane Pharma Ab

(1)

Linsol Co Ltd [kr]; Fourg

(1)

(1)

Lonch Group Ltd; Lonch Gr

(1)

Longhua Hospital Affiliat

(1)

Louis Dreyfus Co Ingredie

(1)

(1)

(1)

Ludwig Maximilians Univ T

(1)

Lukas Heil Betr Gmbh

(1)

Ma\'anshan People\'s Hosp

(1)

Mablink Bioscience [fr];

(1)

Madera Therapeutics Llc

(1)

Maia Pharmaceuticals Inc

(1)

(1)

Marama Labs Ltd

(1)

Marketing Service Center

(1)

Marshall Univ Research Co

(1)

Maxwell Biosciences

(1)

Mayinglong Great Health C

(1)

Maze Therapeutics

(1)

Medicis Pharmaceutical Co

(1)

(1)

Meisida Shanghai Pharmace

(1)

Meiye Biomedical Co Ltd;

(1)

Memorial Sloan Kettering

(1)

Merck Sharp & Dohme Llc [

(1)

Merck Sharp & Dohme Llc [

(1)

Mianyang Weinida Pharmace

(1)

Mineralys Therapeutics In

(1)

Mingowood Pharmacal Llc

(1)

Mitsubishi Tanabe Pharma

(1)

Mizugami Marketing Privat

(1)

Modernatx Inc [us]; Cytom

(1)

Motigenix Singapore Pte L

(1)

Muna Therapeutics

(1)

Myricx Pharma Ltd

(1)

Nadezhda Reproductive Sci

(1)

(1)

Nanjing Daoer Pharmaceuti

(1)

Nanjing Fanhai Pharmaceut

(1)

Nanjing Feilikang Pharmac

(1)

Nanjing Hailing Pharmaceu

(1)

Nanjing Healthnice Pharma

(1)

Nanjing Jiutian Biomedica

(1)

Nanjing Jujiang Biotechno

(1)

Nanjing Kangzhou Pharmace

(1)

Nanjing Nutrabuilding Bio

(1)

Nanjing Theranosta Inc

(1)

Nanjing University of Chi

(1)

Nanjing Weichuangyuan Pha

(1)

Nanjing Well Pharmaceutic

(1)

Nanjing Yinuo Pharmaceuti

(1)

Nanning Hospital of Tradi

(1)

Nantong Haigine Pharma Te

(1)

Nantong Hospital of Tradi

(1)

Nantong Junyue Biopharmac

(1)

Nat Univ Corporation Okay

(1)

National Defense Medical

(1)

National Univ Corporation

(1)

New York University

(1)

NewAmsterdam Pharma

(1)

Nicox Sa [fr]; Fera Pharm

(1)

(1)

Ningbo Eye Hospital

(1)

Ningbo Institute of Mater

(1)

Ningbo Lianhe Photon Tech

(1)

Ningbo Lianhe Photon Tech

(1)

Ningbo Shangwei Hi Tech C

(1)

Ningbo Traditional Chines

(1)

Ningbo University

(1)

Ningbo Yihe Medical Equip

(1)

Ningde Contemporary Futur

(1)

Ningxia Kangtailong Chine

(1)

Ningxia Medical Universit

(1)

Ningxia Qiyuan Pharmaceut

(1)

Niuoushen Medical Shangha

(1)

North China University of

(1)

Northeast Electric Power

(1)

Northwest Normal Universi

(1)

Novartis Ag [ch]; Astex T

(1)

Novartis Ag [ch]; Univers

(1)

Novartis France; A Raymon

(1)

Novilla Pharmaceuticals I

(1)

Npgs Guangdong Biotechnol

(1)

(1)

(1)

Nxera Pharma UK

(1)

Odesai Therapeutics Inc

(1)

Olema Pharmaceuticals

(1)

(1)

Ontario Inst For Cancer R

(1)

(1)

Orion Biotechnology Usa C

(1)

Osanni Bio Inc [us]; Jung

(1)

Owp Pharmaceuticals Inc

(1)

PLA Air Force Medical Uni

(1)

Papyrus Therapeutics Inc

(1)

Paragon Therapeutics

(1)

(1)

Pasithea Therapeutics Cor

(1)

Peking Union Medical Coll

(1)

Peking Union Medical Coll

(1)

Peking Union Medical Coll

(1)

Peking University Third H

(1)

(1)

Petroleo Brasileiro S A P

(1)

(1)

(1)

Pharmaforceiq Inc

(1)

(1)

(1)

Phi Therapeutics Inc

(1)

Pingxiang Health Vocation

(1)

Platinum Pharma Service S

(1)

Popro Shanghai Pharma Sci

(1)

PowerChina Beijing Engine

(1)

Principia Biopharma

(1)

Proteologix Us Inc

(1)

(1)

Pulike Biological Eng Inc

(1)

Pyxis Oncology Inc

(1)

Qiao Yuan Tech Co Ltd

(1)

Qilu Animal Health Produc

(1)

Qilu Hospital of Shandong

(1)

Qingdao Baheal Pharmaceut

(1)

Qingdao Central Hospital

(1)

Qingdao Central Hospital;

(1)

Qingdao Guoxin Pharmaceut

(1)

Qingdao Laoshan Mineral W

(1)

Qingdao Lubemater Lubrica

(1)

Qingdao Municipal Hospita

(1)

Qingdao Orbiepharm Pharma

(1)

Qingdao Ruierweite Biotec

(1)

Qingdao Sino Cell Biomed

(1)

Qingdao University

(1)

Qingdao Wanwuxinsheng Bio

(1)

Qinghai Xiadu Pharmaceuti

(1)

Qionghai Hospital Of Trad

(1)

Quanta Therapeutics

(1)

Qufu Normal University

(1)

Re Vana Therapeutics Ltd

(1)

Recursion Pharmaceuticals

(1)

Regents of the University

(1)

Remab Therapeutics S L

(1)

Remepy Health Ltd

(1)

Renji Hospital Shanghai J

(1)

Replicate Bioscience

(1)

Resdevco Res And Developm

(1)

Resmed Digital Medical In

(1)

Rigerna Therapeutics Co L

(1)

(1)

Ringpu Biotechnology Co L

(1)

Roche Diabetes Care Gmbh

(1)

Rongshan Pharmaceutical C

(1)

Ruenhuei Biopharmaceutica

(1)

Ruijin Hospital Shanghai

(1)

Ruijin Hospital Shanghai

(1)

Ryvu Therapeutics

(1)

Ryvu Therapeutics S A [pl

(1)

Sabic Agri Nutrients

(1)

Sage Therapeutics

(1)

Sagetech Medical Equipmen

(1)

Sainuojin Pharmaceutical

(1)

Salubris Chengdu Biotech

(1)

Sanofi Sa [fr]; UCB Bioph

(1)

Sanya Central Hospital Ha

(1)

Schuckmann Alfred Von

(1)

Second Affiliated Hospita

(1)

Second Hospital of Hebei

(1)

Seoul National University

(1)

Shaanxi Aoshanyaogu Pharm

(1)

Shaanxi Jinzheng Pharmace

(1)

Shaanxi Traditional Chine

(1)

Shaanxi University of Chi

(1)

Shaanxi Xiyue Pharmaceuti

(1)

Shaanxi Yuanzhi Pharmaceu

(1)

Shah Hiral [in]; Shah Gau

(1)

Shandong Anaiysis And Tes

(1)

Shandong Anhong Pharmaceu

(1)

Shandong Anshun Pharmaceu

(1)

Shandong Bestcomm Pharmac

(1)

Shandong Bestcomm Pharmac

(1)

Shandong Borui Pharmaceut

(1)

Shandong Chenxin Fodu Pha

(1)

Shandong Fanhui Biologica

(1)

Shandong Fine Chemical Te

(1)

Shandong Guobang Pharmace

(1)

Shandong Guojiutang Pharm

(1)

Shandong Huanong Biologic

(1)

Shandong Jinan The Third

(1)

Shandong Longchang Animal

(1)

Shandong Lukang Shelile P

(1)

Shandong New Time Pharmac

(1)

Shandong New Time Pharmac

(1)

Shandong New Time Pharmac

(1)

Shandong Nhu Pharmaceutic

(1)

Shandong Simcere Biopharm

(1)

Shandong University

(1)

Shandong Xinhua Pharmaceu

(1)

Shandong Yihe Pharmaceuti

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai Anyea Therapeuti

(1)

Shanghai Baiyang Pharmace

(1)

Shanghai Bao Pharmaceutic

(1)

Shanghai Bowang Pharmaceu

(1)

Shanghai Cell Therapy Gro

(1)

Shanghai City Jingan Dist

(1)

Shanghai Donghai Vocation

(1)

Shanghai EpimAb Biotherap

(1)

Shanghai Fosun Pharmaceut

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hospital Traditi

(1)

Shanghai Huao Co Ltd

(1)

Shanghai Huazhiwo Biomedi

(1)

Shanghai Huilun Pharmaceu

(1)

Shanghai Inst Of Pharmace

(1)

Shanghai Institute Of Mea

(1)

Shanghai Institute of Mat

(1)

Shanghai Institute of Mat

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jingan Pengpu Co

(1)

Shanghai Jingquan Investm

(1)

Shanghai Jingxin Biologic

(1)

Shanghai Maiji Pharmaceut

(1)

Shanghai Meiyue Biotech D

(1)

Shanghai MicuRx Pharmaceu

(1)

Shanghai Mixi Network Tec

(1)

Shanghai No 4 People\'s H

(1)

Shanghai Pharmaceutical S

(1)

Shanghai Pharmaceuticals

(1)

Shanghai Puteshun Health

(1)

Shanghai Qilu Pharmaceuti

(1)

Shanghai Ruotuo Bioscienc

(1)

Shanghai Senhui Medicine

(1)

Shanghai University

(1)

Shanghai University of Te

(1)

Shanghai University of Tr

(1)

Shanghai Yaxin Biotechnol

(1)

Shanghai Yidi Biotechnolo

(1)

Shangrao Aier Eye Hospita

(1)

Shantou Rongcheng Electri

(1)

Shanxi Jinbo Bio Pharmace

(1)

Shanxi Medical University

(1)

Shanxi University of Chin

(1)

Shanxi Xinyu Pharmaceutic

(1)

Shanxi Zhendong Pharmaceu

(1)

Shape Therapeutics

(1)

Shenyang Xindi Pharmaceut

(1)

Shenzhen Antmed

(1)

Shenzhen Bao\'an Traditio

(1)

Shenzhen China Resources

(1)

Shenzhen Finder Biotech C

(1)

Shenzhen Jiebo Biotechnol

(1)

Shenzhen NuboMed Technolo

(1)

Shenzhen Qianzhikang Chin

(1)

Shenzhen Ruihua Pharmaceu

(1)

Shenzhen Ruiji Biotechnol

(1)

Shenzhen University; The

(1)

Shenzhen University; The

(1)

Shenzhen University; Zhej

(1)

Shenzhen Weiguang Biologi

(1)

Shenzhen Xiuli Pharmaceut

(1)

Shenzhen Yueqian Creative

(1)

Shihezi University

(1)

Shijiazhuang Huaxu Pharma

(1)

Shijiazhuang Xinfuda Phar

(1)

Shionogi China Co Ltd

(1)

Shiyan Mulong Biological

(1)

Shujing Biopharma Co Ltd

(1)

Sichuan Academy of Chines

(1)

Sichuan Guorui Pharmaceut

(1)

Sichuan Huhui Software Co

(1)

Sichuan Huiyu Pharmaceuti

(1)

Sichuan Kelun Pharmaceuti

(1)

Sichuan Kelun Pharmaceuti

(1)

Sichuan Tongli Rongsong P

(1)

Sichuan Xingshengyuan Pha

(1)

Signpath Pharma Inc

(1)

Silver Creek Pharmaceutic

(1)

Simcere Remediation Pharm

(1)

Simris Biologics Gmbh

(1)

Sinocaber Pharmaceutical

(1)

Sinopharm A Think Pharmac

(1)

Sinopharm Chuankang Pharm

(1)

Sinopharm Nat Vaccine & S

(1)

Sinopharm Xinjiang Pharma

(1)

Sinopharm Zhijun Shenzhen

(1)

Siolta Therapeutics Inc

(1)

Sjp Biotec Gmbh

(1)

Skyline Biosciences Llc

(1)

(1)

Societe des Produits Nest

(1)

Socpra Sciences Sante Hum

(1)

South China Univ Of Techn

(1)

Southeast University

(1)

Southern University of Sc

(1)

Southwest Jiaotong Univer

(1)

Southwest Petroleum Unive

(1)

Southwest University of S

(1)

Spark Therapeutics

(1)

(1)

Srive Therapeutics Inc

(1)

Standard Pharmaceutical R

(1)

State Grid Information &

(1)

State Grid Zhejiang Elect

(1)

Stichting Terre Nederland

(1)

Sumitomo Pharma America

(1)

Sumitomo Pharmaceutical S

(1)

Sun Pharmaceutical Indust

(1)

Sun Yat-sen Memorial Hosp

(1)

Sun Yat-sen University Ca

(1)

Sun Yat-sen University; G

(1)

Suzhou Aitesen Pharmaceut

(1)

Suzhou Hospital Tradition

(1)

Suzhou Institute of Syste

(1)

Suzhou Kebiao Testing Co

(1)

Suzhou Lixin Pharmaceutic

(1)

Suzhou Oulit Biopharmaceu

(1)

Suzhou Ryan Pharmachem Te

(1)

Suzhou Shengnuowei Biotec

(1)

Suzhou Transcenta Therape

(1)

Symbio Pharmaceuticals Lt

(1)

(1)

Taiwan Mitochondrion Appl

(1)

Taiyuan University of Tec

(1)

(1)

Tandem Diabetes Care Swit

(1)

Temple Otorongo Llc

(1)

Tengzhou Central People\'

(1)

Tennor Therapeutics (Suzh

(1)

Teva Pharmaceuticals

(1)

Texas Tech University Sys

(1)

Thankcome Biotechnology S

(1)

The Affiliated Three Gorg

(1)

The Broad Inst Inc [us];

(1)

The Children\'s Hospital,

(1)

(1)

The People\'s Hospital of

(1)

The People\'s Hospital of

(1)

The Regents Of The Univ O

(1)

The Second People\'s Hosp

(1)

The Second Xiangya Hospit

(1)

The Third Affiliated Clin

(1)

The Third Affiliated Hosp

(1)

The Third Hospital of Nan

(1)

The University of Hong Ko

(1)

The University of Texas

(1)

Thermo Fisher Bioprocessi

(1)

Thryv Therapeutics Inc

(1)

Tianhai Weilai Tianjin Bi

(1)

Tianjin City Zhongtian Sc

(1)

Tianjin Haihe Hospital

(1)

Tianjin Juhong Pension Te

(1)

Tianjin Kailaiying Biotec

(1)

Tianjin Stomatological Ho

(1)

Tianjin Tiankai Medshare

(1)

Tianjin University of Sci

(1)

Tianjin University of Tec

(1)

Tianjin University of Tec

(1)

Tianjin University of Tec

(1)

Tianjin University of Tec

(1)

Tianjin University of Tec

(1)

Tianjin University; Hebei

(1)

Tianjin University; NARI

(1)

Country

X

China Patent News

WIPO Patent News

European Patent News

Taiwan Patent News

Philippines Patent News

Norway Patent News

Status

X

1 - 100 of 1493 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

State Intellectual Property Office of China Publishes Qilu Animal Health Products Co Patent Application for Bovine Parainfluenza Virus Type 3 Inactivated Vaccine and Preparation Me..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Qilu Animal Health Products Co patent application for Bovine Parainfluenza Virus Type 3 Inactivated Vaccine and Preparation Method Thereof. The invention was developed by Teng Qingyuan, Song Xiaofei, Bi Yuyu, Qi Pengfei, Jia Aiqin, Yao Jie and Jin Chuan..

Shanghai Huao Co Ltd Submits Taiwan Patent Application for Multidrug Linker and Antibody-drug Conjugate

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Shanghai Huao Co Ltd has submitted a patent application for Multidrug Linker and Antibody-drug Conjugate. This invention was developed by Sun Wen-long, Meng Xun and Shi Yu. The patent application number is TW20240129204 20240805. The patent publication number is TW202521546 (A). International Patent Classifi..

Taiwan Patent Office Receives Motigenix Singapore Pte Ltd and Reliable Holdings Co Ltd Patent Application for Compositions and Methods for Treating Cancer

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has received Motigenix Singapore Pte Ltd and Reliable Holdings Co Ltd patent application for Compositions and Methods for Treating Cancer. Alipour Mohsen Amir, Yao Zemin and Tseng Kuo-tang developed the invention. The patent application number is TW20230146089 20231128. The patent public..

Jiangsu Dongkang Biomedical Tech Co Ltd Submits Chinese Patent Application for Antibody Specifically Combined with Arabidopsis Thaliana Blue Light Receptor Cryptoflorin CRY1 and Ap..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Jiangsu Dongkang Biomedical Tech Co Ltd has submitted a patent application for Antibody Specifically Combined with Arabidopsis Thaliana Blue Light Receptor Cryptoflorin CRY1 and Application Thereof. This invention was developed by Zhang Lun, Liu Xiaohui, Huang Yajie and Wei Huawei. The patent application nu..

Henan Academy of Medical Sciences Applies for Patent on Application of Isodan Leaf Emodin in Preparation of Icam1 Inhibitor

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Henan Academy of Medical Sciences has applied Chinese patent for Application of Isodan Leaf Emodin in Preparation of Icam1 Inhibitor. Li Lei, Jiang Yong, Jiang Aolin and Zhang Chengyang developed it. The patent application number is CN202511907565 20251217. The patent publication number is CN121534024 (A). ..

Jilin University Files Chinese Patent Application for Application of Emodin in Resisting Carbapenem Drug-resistant Klebsiella Pneumoniae

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Jilin University has filed a patent application for Application of Emodin in Resisting Carbapenem Drug-resistant Klebsiella Pneumoniae. This invention was developed by Guo Na, Geng Jiamin, Deng Xuming and Li Bingyan. The patent application number is CN20261071476 20260120. The patent publication number is C..

State Intellectual Property Office of China Receives Big Health Res Institute of Hefei Integrated Sciences Center Patent Application for Application of Optitiderone in Treatment of..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has received Big Health Res Institute of Hefei Integrated Sciences Center patent application for Application of Optitiderone in Treatment of Malignant Ascites. He Aina, Niu Gengming, Wei Guiying and Xu Heming developed the invention. The patent application number ..

Changchun University of Chinese Medicine Submits Chinese Patent Application for Ginsenoside Composition and Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Changchun University of Chinese Medicine has submitted a patent application for Ginsenoside Composition and Application Thereof. This invention was developed by Sun Tianxia, Li Xiaohua, Li Hongling, Liu Hailong, Wang Yuming, Lian Wenhui, Keigo and Zhao Yu. The patent application number is CN202511719346 202..

State Intellectual Property Office of China Releases Yunnan Yunke Biotechnology Research Institute Patent Application for Application of Mir-8069 Inhibitor

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Yunnan Yunke Biotechnology Research Institute patent application for Application of Mir-8069 Inhibitor. This invention was developed by Zhu Lingying, Yi Xuetao and Meng Tian. The patent application number is CN20261064290 20260119. The patent publicat..

State Intellectual Property Office of China Publishes Xiamen Jinyanda Protection Technology Patent Application for Anti-inflammatory Liquid Dressing and Preparation Method Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Xiamen Jinyanda Protection Technology patent application for Anti-inflammatory Liquid Dressing and Preparation Method Thereof. The invention was developed by Ding Jixi and Chen Meng. The patent application number is CN202511622666 20251107. The paten..

The People's Hospital of Xuancheng City Files Chinese Patent Application for Pharmacy Tablet Distribution Device

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- The People's Hospital of Xuancheng City has filed a patent application for Pharmacy Tablet Distribution Device. This invention was developed by Zhang Lingling. The patent application number is CN20251251865 20251231. The patent publication number is CN121536745 (A). International Patent Classification codes..

Shihezi University Submits Chinese Patent Application for Gallate Amide Bridged Thiazole Derivative as Well as Preparation Method and Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Shihezi University has submitted a patent application for Gallate Amide Bridged Thiazole Derivative as Well as Preparation Method and Application Thereof. This invention was developed by Zhang Jie, Han Bo, Mei Jinshan, Sun Yakun, Guo Liang, Xiong Lanli and Hu Wencong. The patent application number is CN2025..

State Intellectual Property Office of China Publishes Chongqing Traditional Chinese Medicine Hospital Patent Application for Method for Extracting Isopentenyl Flavonoid Compound fr..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Chongqing Traditional Chinese Medicine Hospital patent application for Method for Extracting Isopentenyl Flavonoid Compound from Black Mulberry. The invention was developed by Tang Ping, Leng Jing, Guo Xiaohong, Du Hua, Wu Yi and Li Linzhi. The paten..

Beijing University of Chinese Medicine Submits Chinese Patent Application for Crotonane Diterpenoid Glycoside as Well as Derivative, Preparation Method and Application of Crotonane..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Beijing University of Chinese Medicine has submitted a patent application for Crotonane Diterpenoid Glycoside as Well as Derivative, Preparation Method and Application of Crotonane Diterpenoid Glycoside. This invention was developed by Zhang Jia, Xu Jiekun, Du Jialu, Zhou Fulin and Chen Yilin. The patent ap..

Nanjing University of Chinese Medicine Files Chinese Patent Application for Secondary Gypenoside Derivative as Well as Preparation Method and Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Nanjing University of Chinese Medicine has filed a patent application for Secondary Gypenoside Derivative as Well as Preparation Method and Application Thereof. This invention was developed by Zhang Yinan, Wang Hanghang, Zhang Yu and Chai Qian. The patent application number is CN20261000976 20260104. The pa..

Baisite Pharmaceutical Guangzhou Co Ltd Submits Chinese Patent Application for High-transparency Schizophyllum Commune Polysaccharide as Well as Preparation Method and Cosmetics Th..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Baisite Pharmaceutical Guangzhou Co Ltd has submitted a patent application for High-transparency Schizophyllum Commune Polysaccharide as Well as Preparation Method and Cosmetics Thereof. This invention was developed by Sun Yunqi, Pei Yunlin, Yan Kunjun, Wu Mingjie and Yu Wentao. The patent application numbe..

State Intellectual Property Office of China Releases Heilongjiang University of Chinese Medicine Patent Application for Method for Extracting Active Polysaccharide from Red Paeony ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Heilongjiang University of Chinese Medicine patent application for Method for Extracting Active Polysaccharide from Red Paeony Root by Using Eutectic Solvent. This invention was developed by Liu Yan, Deng Fanying, Yi Qiang Jake Zhang, Wu Jiatong, Liu Yua..

Wuhan Ruixinhe Biotechnology Co Ltd Submits Chinese Patent Application for Pgi Monoclonal Antibody Combination for Pepsinogen I Detection and Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Wuhan Ruixinhe Biotechnology Co Ltd has submitted a patent application for Pgi Monoclonal Antibody Combination for Pepsinogen I Detection and Application Thereof. This invention was developed by Chen Ying, Zeng Xiangdi and Lin Yusheng. The patent application number is CN20261066240 20260119. The patent publ..

State Intellectual Property Office of China Releases Zhongnan Hospital Of Wuhan University Patent Application for Anti-cdh11 Scfv Antibody and Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Zhongnan Hospital Of Wuhan University patent application for Anti-cdh11 Scfv Antibody and Application Thereof. This invention was developed by Wang Huiming and Zhen Wenjing. The patent application number is CN202511790919 20251201. The patent publicat..

State Intellectual Property Office of China Receives Sun Yat Sen University Shenzhen and Sun Yat-sen University Patent Application for Human and Mouse Serum Albumin Cross Reaction ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has received Sun Yat Sen University Shenzhen and Sun Yat-sen University patent application for Human and Mouse Serum Albumin Cross Reaction Nanometer Antibody Derived from Fully Synthetic Antibody Library. Wang Jiaqi, Jiang Xinyi, Li Xinyu and Huang Yuxiang developed..

Jiangsu Dongkang Biomedical Tech Co Ltd Submits Patent Application for Targeting Light-activated Fluorescent Protein Dronpa Antibody and Related Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Jiangsu Dongkang Biomedical Tech Co Ltd has submitted a patent application for Targeting Light-activated Fluorescent Protein Dronpa Antibody and Related Application Thereof. Zhang Lun, Liu Xiaohui, Huang Yajie and Wei Huawei developed the invention. The patent application number is CN202511723311 20251121. ..

State Intellectual Property Office of China Releases Jiangsu Dongkang Biomedical Tech Co Ltd Patent Application for Monoclonal Antibody for Detecting Soybean Phytochrome Phyb Prote..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Jiangsu Dongkang Biomedical Tech Co Ltd patent application for Monoclonal Antibody for Detecting Soybean Phytochrome Phyb Protein. This invention was developed by Zhang Lun, Liu Xiaohui, Huang Yajie and Wei Huawei. The patent application number is CN2..

State Intellectual Property Office of China Publishes Spirit Jinyu Biological Pharmaceutical Co Ltd Patent Application for Preparation Method and Application of Bovine Clostridium ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Spirit Jinyu Biological Pharmaceutical Co Ltd patent application for Preparation Method and Application of Bovine Clostridium Perfringens Alpha Toxin Renaturation Protein. The invention was developed by Hu Lihong, Jin Ying, Wen Baopeng, Kang Jian, Liu Z..

Jewim Pharmaceutical (Shandong) Submits Chinese Patent Application for Preparation Method of L-pyroglutamic Acid Etogliflozin

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Jewim Pharmaceutical (Shandong) has submitted a patent application for Preparation Method of L-pyroglutamic Acid Etogliflozin. This invention was developed by Guo Xiao, Sang Wei, Cao Xueli, Sun Yingji, Li Tiejun and Ma Jixiao. The patent application number is CN202511705019 20251120. The patent publication nu..

State Intellectual Property Office of China Publishes Guangdong University of Technology Patent Application for Anti-tumor Drug Compound Targeting Mitochondrial Topoisomerase I as ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Guangdong University of Technology patent application for Anti-tumor Drug Compound Targeting Mitochondrial Topoisomerase I as Well as Preparation Method and Application of Anti-tumor Drug Compound. The invention was developed by Xiong Kai, Yang Shuai, Z..

Taiwan Patent Office Publishes Kite Pharma Patent Application for Apparatuses, Systems, and Methods for Storing and Transporting a Temperature Sensitive Material

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has published Kite Pharma patent application for Apparatuses, Systems, and Methods for Storing and Transporting a Temperature Sensitive Material. The invention was developed by Obrad Frank D and Wallin Brian A. The patent application number is TW20240128889 20240802. The patent publication..

Central South University Submits Patent Application for Aromatic Fused Ring Compound as Well as Preparation Method and Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Central South University has submitted a patent application for Aromatic Fused Ring Compound as Well as Preparation Method and Application Thereof. Xiang Haoyue, Pan Jiayi, Ai Juntao and Tang Jingyi developed the invention. The patent application number is CN202511726178 20251124. The patent publication num..

State Intellectual Property Office of China Publishes Tianjin University Patent Application for Preparation Method and System of Spherical Epsilon-CL-20 Crystal

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Tianjin University patent application for Preparation Method and System of Spherical Epsilon-CL-20 Crystal. The invention was developed by Dang Leping, Liu Guozhao, Zhai Lina, Sun Chenghui and Pang Siping. The patent application number is CN202511495..

State Intellectual Property Office of China Publishes Soochow University Patent Application for Benzoic Acid-8-azabicyclo [3.2. 1] Octyl-3-yl Ester Derivative, Preparation Method, ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Soochow University patent application for Benzoic Acid-8-azabicyclo [3.2. 1] Octyl-3-yl Ester Derivative, Preparation Method, Pharmaceutical Composition and Application. The invention was developed by Zhen Xuechu, Ye Na, Liu Bingyan, Ma Zhixue and Hu Ji..

State Intellectual Property Office of China Publishes Changchun University of Technology Patent Application for Synthesis and Antitumor Activity Research of Coumarin Skeleton Modif..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Changchun University of Technology patent application for Synthesis and Antitumor Activity Research of Coumarin Skeleton Modified Drug Micromolecules. The invention was developed by Xia Yan and Li Zuoyi. The patent application number is CN202511738920 ..

China Pharmaceutical University Applies for Patent on Benzamide-oxadiazole Skeleton Compound as Well as Preparation Method and Application Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- China Pharmaceutical University has applied Chinese patent for Benzamide-oxadiazole Skeleton Compound as Well as Preparation Method and Application Thereof. Sun Haopeng, Wang Yuanyuan and Ren Xinyu developed it. The patent application number is CN202511759656 20251127. The patent publication number is CN12153..

Jiangnan University Files Chinese Patent Application for Synthesis Scheme and Application of Chiral Bisoxazoline Ligand

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Jiangnan University has filed a patent application for Synthesis Scheme and Application of Chiral Bisoxazoline Ligand. This invention was developed by Liu Bingxue, Wang Jing, Dong Yu and Liu Yumeng. The patent application number is CN202511929545 20251219. The patent publication number is CN121537359 (A). Int..

State Intellectual Property Office of China Publishes East China University of Science and Technology Patent Application for Axial Chiral N-heterocyclic Carbene Ligand as Well as P..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published East China University of Science and Technology patent application for Axial Chiral N-heterocyclic Carbene Ligand as Well as Preparation Method and Application Thereof. The invention was developed by Zhang Zhipeng, Chen Yayun, Li Chuanliang and Cen Shou..

Shanghai Jiao Tong University Applies for Patent on Two-dimensional Material Wet Transfer Device and Two-dimensional Material Wet Transfer Method

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Shanghai Jiao Tong University has applied Chinese patent for Two-dimensional Material Wet Transfer Device and Two-dimensional Material Wet Transfer Method. Liu Yue, Chen Yumeng, You Shuting, Shen Shuxin and Fan Tongxiang developed it. The patent application number is CN202511718117 20251121. The patent public..

Hunan Nonferrous Metals Vocational & Technical College Submits Chinese Patent Application for Preparation of Porous Nano-zinc Oxide Photocatalyst and Application of Porous Nano-zin..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Hunan Nonferrous Metals Vocational & Technical College has submitted a patent application for Preparation of Porous Nano-zinc Oxide Photocatalyst and Application of Porous Nano-zinc Oxide Photocatalyst in Antibiotic Degradation. This invention was developed by Dang Mingming, Guo Yongyan, Tian Yanfei, Ou Yu, Li..

China Resources Sanjiu Medical & Pharmaceutical Seeks Patent for Mixture Mixing Uniformity Control Method, System and Equipment, Medium and Product

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- China Resources Sanjiu Medical & Pharmaceutical has sought patent for Mixture Mixing Uniformity Control Method, System and Equipment, Medium and Product. This invention was developed by Ouyang Yanqin, Li Xia, Qiao Rifa, Chen Xiaoyang, Chen Zhao, Xie Cong, Huang Yuanhong and Tu Xiangjun. The patent application..

Austar Pharmaceutical Equipment (Shijiazhuang) Submits Patent Application for Joint Control Method of Weight-loss Type Feeding Unit for Pharmacy

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Austar Pharmaceutical Equipment (Shijiazhuang) has submitted a patent application for Joint Control Method of Weight-loss Type Feeding Unit for Pharmacy. He Guoqiang, Chen Yuewu, Zhang Pengfei, Chen Haoning, Wu Hengyi and Lan Xiaoling developed the invention. The patent application number is CN202511627285 20..

Yiteng Pharmaceutical (Suzhou) Submits Patent Application for Waste Recovery Treatment Device for Medicine Production

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Yiteng Pharmaceutical (Suzhou) has submitted a patent application for Waste Recovery Treatment Device for Medicine Production. Qi Jingke, Zhu Zhaoming and Chen Yunpeng developed the invention. The patent application number is CN202511799626 20251202. The patent publication number is CN121534451 (A). Internati..

Tianjin University Seeks Patent for Layering Device and Method Capable of Realizing Multi-layer Fluid

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Tianjin University has sought patent for Layering Device and Method Capable of Realizing Multi-layer Fluid. This invention was developed by Yan Xiang, Peng Zhun, Feng Weipeng and Bai Zhigang. The patent application number is CN202511759339 20251127. The patent publication number is CN121534420 (A). Internatio..

Hubei Gongtong Pharmaceutical Files Chinese Patent Application for Distillation Refining Equipment and Vitamin D3 Crude Product Purification Process Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Hubei Gongtong Pharmaceutical has filed a patent application for Distillation Refining Equipment and Vitamin D3 Crude Product Purification Process Thereof. This invention was developed by Xi Zubin, Li Minglei and Xi Siyi. The patent application number is CN202511896794 20251216. The patent publication number ..

Hunan Meibai Biological Pharmaceutical Co Ltd Submits Chinese Patent Application for Method for Reversing Senescence State of Mesenchymal Stem Cells by Combined Application of Mech..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Hunan Meibai Biological Pharmaceutical Co Ltd has submitted a patent application for Method for Reversing Senescence State of Mesenchymal Stem Cells by Combined Application of Mechanical Force Stimulation and Alpha-ketoglutaric Acid Treatment. This invention was developed by Liu Xiaojing, Wei Qiang and Xiao E...

Ruenhuei Biopharmaceuticals Inc Applies for Patent on Influenza Vaccine Comprising Whole Virus, Split Virus or Virus Like Particles with Partially Glycosylated Surface Viral Glycop..

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Ruenhuei Biopharmaceuticals Inc has applied Taiwan patent for Influenza Vaccine Comprising Whole Virus, Split Virus or Virus Like Particles with Partially Glycosylated Surface Viral Glycoprotein. Chen Juine-ruey, Hsiao Jane and Wu Jia-ying developed it. The patent application number is TW20230145298 20231123..

Hoffmann La Roche Submits Patent Application for Process for the Preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione Compounds

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Hoffmann La Roche has submitted a patent application for Process for the Preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione Compounds. Santandrea Ernesto and Thome-pfeiffer Isabelle developed the invention. The patent application number is TW20240129497 20240807. The patent publication..

Taiwan Patent Office Receives Novartis Patent Application for Substituted Imidazoarenes and Methods of Their Use

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has received Novartis patent application for Substituted Imidazoarenes and Methods of Their Use. Cole Justin, Johnson Alyssa Miranda, Karki Rajesh, Krautwald Simon, Meier Peter, Palacios Daniel Steven, Parthasarathy Saravanan, Patnaik Anup, Peukert Stefan, Ross Alistair Edward Jack, Wang Ka..

Principia Biopharma Submits Taiwan Patent Application for Process of Making 2-[(3r)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-m..

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Principia Biopharma has submitted a patent application for Process of Making 2-[(3r)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile and Solvate Forms Thereof. This invention was developed by Comte Myriam, C..

Taiwan Patent Office Receives Boehringer Ingelheim International Patent Application for Process for the Manufacture of a HER2 Inhibitor

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has received Boehringer Ingelheim International patent application for Process for the Manufacture of a HER2 Inhibitor. Chong Eugene, Dong Weitong, Li Ruo-shi, Mulder Jason Alan and Trofimov Alexander developed the invention. The patent application number is TW20240127906 20240726. The pat..

Taiwan Patent Office Receives Ventus Therapeutics US Patent Application for Solid Freebase Forms of 5-chloro-2-(4-((2-hydroxy-2-methylpropyl)amino)pyrido[3,4-d]pyridazin-1-yl)pheno..

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has received Ventus Therapeutics US patent application for Solid Freebase Forms of 5-chloro-2-(4-((2-hydroxy-2-methylpropyl)amino)pyrido[3,4-d]pyridazin-1-yl)phenol for Inhibiting NLRP3 and Uses Thereof. Murphy Luke J developed the invention. The patent application number is TW20240144477 ..

Ascletis Pharma China Co Limited Files Taiwan Patent Application for GLP-1R Agonist and Therapeutic Method Thereof

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Ascletis Pharma China Co Limited has filed a patent application for GLP-1R Agonist and Therapeutic Method Thereof. This invention was developed by Liang Bin, Wu Jinzi Jason and Yang Bai-ling. The patent application number is TW20240134832 20240913. The patent publication number is TW202521534 (A). Internatio..

Ascletis Pharma China Co Limited Files Taiwan Patent Application for GLP-1R Agonist and Therapeutic Method Thereof

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Ascletis Pharma China Co Limited has filed a patent application for GLP-1R Agonist and Therapeutic Method Thereof. This invention was developed by Liang Bin, Wu Jinzi Jason and Yang Bai-ling. The patent application number is TW20240134831 20240913. The patent publication number is TW202521533 (A). Internatio..

Hanmi Pharmaceutical Seeks Patent for Novel Phthalazine Derivative Compound as SOS1 Inhibitor and Use Thereof

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Hanmi Pharmaceutical has sought patent for Novel Phthalazine Derivative Compound as SOS1 Inhibitor and Use Thereof. This invention was developed by Kong Tae-yeon, Kim Min-jeong, Park Won-gi, Byun Joo-yun, Ahn Young-gil, Jung Seung-hyun and Choi Jae-yul. The patent application number is TW20240131616 20240822..

Taiwan Patent Office Publishes Jiangsu Hengrui Pharmaceuticals Co Ltd and Shanghai Hengrui Pharmaceutical Patent Application for a Heteroaryl Compound, a Preparation Method Thereof..

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has published Jiangsu Hengrui Pharmaceuticals Co Ltd and Shanghai Hengrui Pharmaceutical patent application for a Heteroaryl Compound, a Preparation Method Thereof and a Medical Use Thereof. The invention was developed by Li Xin, Shen Feng, Gui Bin, Wang Wei, Kong Lu-yao and He Feng. The..

EA Pharma Submits Patent Application for Method for Producing Compounds

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- EA Pharma has submitted a patent application for Method for Producing Compounds. Minamikawa Ryo, Magata Yuya, Tsubaki Kota and Yamasaki Takeshi developed the invention. The patent application number is TW20240137901 20241004. The patent publication number is TW202521518 (A). International Patent Classification..

Astrogen Submits Taiwan Patent Application for 5-aminolevulinic Acid Derivative and Pharmaceutical Composition Containing the Same

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Astrogen has submitted a patent application for 5-aminolevulinic Acid Derivative and Pharmaceutical Composition Containing the Same. This invention was developed by Hwang Su-kyeong and Ryu Hyung-chul. The patent application number is TW20240127342 20240722. The patent publication number is TW202521504 (A). Int..

State Intellectual Property Office of China Publishes Affiliated Hospital Xuzhou Medical University Patent Application for Block Chain-based Drug Cross-regional Transfer Tracing an..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Affiliated Hospital Xuzhou Medical University patent application for Block Chain-based Drug Cross-regional Transfer Tracing and Multi-subject Data Sharing System. The invention was developed by Qin Yawei, Zou Shijiao and Li Na. The patent application n..

State Intellectual Property Office of China Receives Heilongjiang Sengong Traditional Chinese Medicinal Mat Industry Development Co Ltd Patent Application for Block Chain-based Gen..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has received Heilongjiang Sengong Traditional Chinese Medicinal Mat Industry Development Co Ltd patent application for Block Chain-based Genuine Medicinal Material Whole-process Identifying and Tracing Method. Liu Yingming, Sun Xin, Jiang Tao and Sun Guangnan develop..

Peking University First Hospital Peking University First Clinical Medical College Submits Patent Application for Application of SNP (single Nucleotide Polymorphism) Marker of PEAR1..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Peking University First Hospital Peking University First Clinical Medical College has submitted a patent application for Application of SNP (single Nucleotide Polymorphism) Marker of PEAR1 in Predicting Curative Effect of Antithrombotic Drug on Thrombus. Xiang Qian, Liu Zhiyan, Cui Yimin, Wang Zhe and Qiu Zhiw..

Qinghai Xiadu Pharmaceutical Co Ltd Submits Chinese Patent Application for Ursodesoxycholic Acid Production Process Based on Double-enzyme Method

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Qinghai Xiadu Pharmaceutical Co Ltd has submitted a patent application for Ursodesoxycholic Acid Production Process Based on Double-enzyme Method. This invention was developed by Gong Lichang, Zhang Li, Xu Yonglian, Han Qi, Wang Weiyu and Li Xiangui. The patent application number is CN202511732620 20251124...

State Intellectual Property Office of China Releases Jiangxi Fangzhu Pharmaceutical Co Ltd Patent Application for Functional Fermentation Product Preparation Process Based on Direc..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Jiangxi Fangzhu Pharmaceutical Co Ltd patent application for Functional Fermentation Product Preparation Process Based on Directional Conversion of Bean Dregs. This invention was developed by Song Xizhong, Qian Limei, Chen Peiwu, Yin Wei, Zheng Jinfang, ..

Shandong Anshun Pharmaceutical Co Ltd Submits Patent Application for Biosynthesis Method of Idoxaban Tosylate Chiral Intermediate

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Shandong Anshun Pharmaceutical Co Ltd has submitted a patent application for Biosynthesis Method of Idoxaban Tosylate Chiral Intermediate. Yin Huanhuan, Yang Qingkun, Fan Changying, Sun Zhengjun and E Delin developed the invention. The patent application number is CN202511720879 20251121. The patent publica..

State Intellectual Property Office of China Receives Big Health Res Institute of Hefei Integrated Sciences Center and Chongqing Jiashiteng Pharmaceutical Co Ltd Patent Application ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has received Big Health Res Institute of Hefei Integrated Sciences Center and Chongqing Jiashiteng Pharmaceutical Co Ltd patent application for Stable Transfection Cell Strain for Detecting Activity of Wnt and/or R-spondin Family Cytokines as Well as Construction Met..

Hunan Space Folding Internet Tech Co Ltd Submits Patent Application for Inventory Analysis and Management Optimization Method of Intelligent Pharmacy Management System

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Hunan Space Folding Internet Tech Co Ltd has submitted a patent application for Inventory Analysis and Management Optimization Method of Intelligent Pharmacy Management System. Ouyang Peng, Chen Long and Zhang Jing developed the invention. The patent application number is CN20261071009 20260120. The patent ..

State Intellectual Property Office of China Publishes Shenzhen Weiguang Biological Products Patent Application for Whole-process Verification Method, Mistake Proofing Method and Sy..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Shenzhen Weiguang Biological Products patent application for Whole-process Verification Method, Mistake Proofing Method and System for Medicine. The invention was developed by Zhang Zhan, Yin Letu, Liu Yihao, Xie Lijian, Zhang Yutong, Yang Guang and Wan..

State Intellectual Property Office of China Releases Wuhan Guanggu Zhongyuan Pharmaceutical Co Ltd Patent Application for Method for Amplifying Mesenchymal Stem Cells Derived from ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Wuhan Guanggu Zhongyuan Pharmaceutical Co Ltd patent application for Method for Amplifying Mesenchymal Stem Cells Derived from Pluripotent Stem Cells. This invention was developed by Zhang Yu, Shi Xiaoyu, Qi Qi, Song Meng, Wang Aitong and Cai Xiaoyu. ..

State Intellectual Property Office of China Releases Wuhan Guanggu Zhongyuan Pharmaceutical Co Ltd Patent Application for Preparation Method of Mesenchymal Stem Cell-like Precursor..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Wuhan Guanggu Zhongyuan Pharmaceutical Co Ltd patent application for Preparation Method of Mesenchymal Stem Cell-like Precursor Cells, Culture Medium Composition and Application of Culture Medium Composition. This invention was developed by Zhang Yu, Shi..

State Intellectual Property Office of China Publishes Ningxia Qiyuan Pharmaceutical Co Ltd Patent Application for Bacillus High-yield Strain for Producing Riboflavin and Applicatio..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Ningxia Qiyuan Pharmaceutical Co Ltd patent application for Bacillus High-yield Strain for Producing Riboflavin and Application Thereof. The invention was developed by Guo Huifen, Hu Jihong, Liu Xiaoqiang, Zhu Na, Ren Xiaofang, Chen Huiqin, Xing Li, Zha..

Southern University of Science and Technology Files Chinese Patent Application for Cell Pulsation Culture Device, Drug Screening Method and Manufacturing Process

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Southern University of Science and Technology has filed a patent application for Cell Pulsation Culture Device, Drug Screening Method and Manufacturing Process. This invention was developed by Luo Zhi and Zhang Yuhang. The patent application number is CN202511566899 20251030. The patent publication number is ..

State Intellectual Property Office of China Releases Yantai Advanced Mat And Green Manufacturing Shandong Laboratory and Lanzhou Institute of Chemical Physics, Chinese Academy of S..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Yantai Advanced Mat And Green Manufacturing Shandong Laboratory and Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences patent application for Solid Lubricating Coating Based on Graphene-amorphous Calcium Carbonate and Preparation Method T..

Yili Quanlu Pharmaceutical Co Ltd Applies for Patent on Parallel Continuous Extraction Process of Deer-horn Glue

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Yili Quanlu Pharmaceutical Co Ltd has applied Chinese patent for Parallel Continuous Extraction Process of Deer-horn Glue. Shi Yuxi, Liu Wei, Li Yanmei, Lu Caixia, Han Fang and Huang Hui developed it. The patent application number is CN202511863137 20251211. The patent publication number is CN121537644 (A)...

Tianjin Xincheng Kangda Pharmaceutical Applies for Patent on Preparation Method of Medicinal 6-arm-polyethylene Glycol-succinimide Glutarate (amido Bond)

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Tianjin Xincheng Kangda Pharmaceutical has applied Chinese patent for Preparation Method of Medicinal 6-arm-polyethylene Glycol-succinimide Glutarate (amido Bond). Chen Shuangyong, Xie Hui, Meng Xianghai, Cheng Xudong, Cheng Guorui and Shi Qi developed it. The patent application number is CN202511976547 20251..

State Intellectual Property Office of China Receives Tianjin University Patent Application for Preparation Method of Layered Aluminum-based Composite Material

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has received Tianjin University patent application for Preparation Method of Layered Aluminum-based Composite Material. Li Chong, Tan Dong, Yao Haining and Cui Lei developed the invention. The patent application number is CN202511878863 20251212. The patent publicat..

Taiwan Patent Office Publishes ADARx Pharmaceuticals Patent Application for Coagulation Factor Xi-modulating Compositions and Methods of Use Thereof

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has published ADARx Pharmaceuticals patent application for Coagulation Factor Xi-modulating Compositions and Methods of Use Thereof. The invention was developed by Li Zhen, Zhu Rui, Macleod Alan Robert and Fultz Kimberly. The patent application number is TW20240127167 20240719. The patent ..

UCB Biopharma Submits Patent Application for Knob Domain Proteins

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- UCB Biopharma has submitted a patent application for Knob Domain Proteins. Lawson Alastair David Griffiths, Macpherson Alexander and Kuravskiy Mikhail developed the invention. The patent application number is TW20240136870 20240927. The patent publication number is TW202521590 (A). International Patent Classif..

Daan Biotherapeutics Co Ltd Submits Patent Application for Anti-ceacam5 Antibodies and Uses Therof

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Daan Biotherapeutics Co Ltd has submitted a patent application for Anti-ceacam5 Antibodies and Uses Therof. Cho Byoung-chul, Park Sae-young, Yoon Ju-gyeong, Park Ji-young, Kim Young-seob and Kim Dong-ho developed the invention. The patent application number is TW20240142927 20241108. The patent publication n..

Intellia Therapeutics Files Taiwan Patent Application for CD70 CAR-t Compositions and Methods for Cell-based Therapy

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Intellia Therapeutics has filed a patent application for CD70 CAR-t Compositions and Methods for Cell-based Therapy. This invention was developed by Lam Michael, Miller Ian, Chivukula Raghavender Siva Vijaya, Prodeus Aaron, Kilic Ozgun, Sharma Palak, Liu Dai, Shevale Nachiket Narendra, Schultes Birgit, Zhang Yo..

Qilu Hospital of Shandong University Submits Chinese Patent Application for Cache Medicine Taking Device for Medicine Basket

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Qilu Hospital of Shandong University has submitted a patent application for Cache Medicine Taking Device for Medicine Basket. This invention was developed by Li Dongliang, Li Liang, Zhang Xiyan and Zhang Qian. The patent application number is CN202511614654 20251106. The patent publication number is CN1215366..

State Intellectual Property Office of China Releases Wenzhou People's Hospital Patent Application for Traditional Chinese Medicine Weighing and Packaging Device for Traditional Chi..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released Wenzhou People's Hospital patent application for Traditional Chinese Medicine Weighing and Packaging Device for Traditional Chinese Medicine Pharmacist. This invention was developed by Yang Jinzhao, Wu Yu and Zeng Guowu. The patent application number is..

Orion Applies for Patent on Process for the Preparation of Androgen Receptor Antagonists and Intermediates Thereof

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Orion has applied Taiwan patent for Process for the Preparation of Androgen Receptor Antagonists and Intermediates Thereof. Kataja Antti developed it. The patent application number is TW20240130663 20240815. The patent publication number is TW202521513 (A). International Patent Classification codes are A61K3..

Taiwan Patent Office Receives TYK Medicines Patent Application for Pharmaceutical Composition of Pyrimidine Derivative

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- Taiwan Patent Office has received TYK Medicines patent application for Pharmaceutical Composition of Pyrimidine Derivative. Niu Cheng-shan, Zheng Mao-lin, Wang Guo-hui, Liang A-peng, Chen Shaoqing, Li Jun, Wu Yusheng, Li Xue, Qiu Jing-wen and Zhen Zi-rui developed the invention. The patent application number..

AstraZeneca AB Submits Patent Application for Uracil Compounds

Pharmaceutical

| Mon 08 Jun 2026

Taipei, June 8 -- AstraZeneca AB has submitted a patent application for Uracil Compounds. Branalt Leif Jonas Mikael, Inghardt Tord Bertil, Miljkovic Filip and Foster Robert William developed the invention. The patent application number is TW20240144007 20241115. The patent publication number is TW202521529 (A). International ..

Beijing University of Chemical Technology Applies for Patent on Biological Medicine Industry Chain Green Efficiency Evaluation Method and Device and Electronic Equipment

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Beijing University of Chemical Technology has applied Chinese patent for Biological Medicine Industry Chain Green Efficiency Evaluation Method and Device and Electronic Equipment. Chen Wenhui, Lei Yalin, Cao Zimin, Li Li, Jiang Yong, Shao Zhenquan, Chen Na and Zhang Yidan developed it. The patent application ..

Dana Farber Cancer Institute Inc and President and Fellows of Harvard College Obtain Patent for Degraders of Hepatitis C Virus NS3/4a Protein

Pharmaceutical

| Fri 05 Jun 2026

Alexandria, June 6 -- Dana Farber Cancer Institute Inc and President and Fellows of Harvard College have obtained a patent for degraders of hepatitis c virus NS3/4a protein. This invention was developed by Gray Nathanael S, Zhang Tinghu, Yang Priscilla, De Wispelaere Melissanne and Du Guangyan. The patent application number i..

University De Lille, Centre National De La Recherche Scient, Yncrea Hauts De France, University Du Littoral Cote Dopale, University Dartois, University Polytechnique Des Hauts De F..

Pharmaceutical

| Fri 05 Jun 2026

Alexandria, June 6 -- University De Lille, Centre National De La Recherche Scient, Yncrea Hauts De France, University Du Littoral Cote Dopale, University Dartois, University Polytechnique Des Hauts De France, Centrale Lille Institute and Add2life GmbH have received a patent for Lactic Acid Bacteria Strain—antibacterial Peptide..

Fasikl Incorporated and Hangzhou Fasikl Tech Co Ltd Awarded Patent for H-bridge Control Circuit for Electro-stimulation Therapeutic Instrument for Neuromodulation

Pharmaceutical

| Fri 05 Jun 2026

Alexandria, June 6 -- Fasikl Incorporated and Hangzhou Fasikl Tech Co Ltd have been awarded a patent for H-bridge Control Circuit for Electro-stimulation Therapeutic Instrument for Neuromodulation. This invention was developed by Wang Wei, Wang Baitong, Nguyen Jules Anh Tuan and Ye Bing. The patent application number is US202..

The Second People's Hospital of Huai'an Submits Patent Application for Narcotic Drug Treatment Method Based on Credible Verification Closed-loop Intelligence

Pharmaceutical

| Sun 07 Jun 2026

Beijing, June 8 -- The Second People's Hospital of Huai'an has submitted a patent application for Narcotic Drug Treatment Method Based on Credible Verification Closed-loop Intelligence. Shen Yang, Ge Fei and Jiang Yinxia developed the invention. The patent application number is CN202511717266 20251121. The patent publication nu..

Qufu Normal University Submits Chinese Patent Application for Drug-disease Association Prediction Method and System, Computer Equipment and Medium

Pharmaceutical

| Sun 07 Jun 2026

Beijing, June 8 -- Qufu Normal University has submitted a patent application for Drug-disease Association Prediction Method and System, Computer Equipment and Medium. This invention was developed by Shang Junliang, Kong Xiaotong, Sun Yan, Tang Xiaoqi, Yan Chao, Qiu Defu and Wang Hanxiang. The patent application number is CN20..

Sun Yat-sen University Cancer Center Sun Yat-sen University Affiliated Cancer Hospital Sun Yat-sen University Cancer Submits Chinese Patent Application for Medical Anesthetic Spray..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Sun Yat-sen University Cancer Center Sun Yat-sen University Affiliated Cancer Hospital Sun Yat-sen University Cancer has submitted a patent application for Medical Anesthetic Spraying Device. This invention was developed by Yang Yongfeng and Kuang Jiamin. The patent application number is CN202511929949 202512..

Zhejiang University Submits Chinese Patent Application for Infected Lacuna Medicine Injection and Flushing Channel Device

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Zhejiang University has submitted a patent application for Infected Lacuna Medicine Injection and Flushing Channel Device. This invention was developed by Hu Rongrong, Mo Lujiao, Jin Wangyan, Luo Songsong, Lai Jiawei and Huang Cheng. The patent application number is CN20261034928 20260112. The patent publicat..

Renji Hospital Shanghai Jiao Tong University School of Medicine Submits Patent Application for Montmorillonite-based Oral Intestinal In-situ Fermentation System as Well as Preparat..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Renji Hospital Shanghai Jiao Tong University School of Medicine has submitted a patent application for Montmorillonite-based Oral Intestinal In-situ Fermentation System as Well as Preparation Method and Application Thereof. Liu Jinyao and Lin Sisi developed the invention. The patent application number is CN20..

Changzhou University Files Chinese Patent Application for Pharmaceutical Composition for Protecting Gastric Mucosa, Gastric Floating Buoyant Raft System of Pharmaceutical Compositi..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Changzhou University has filed a patent application for Pharmaceutical Composition for Protecting Gastric Mucosa, Gastric Floating Buoyant Raft System of Pharmaceutical Composition and Preparation Method of Gastric Floating Buoyant Raft System. This invention was developed by Wang Yajing, Wang Shan, Huang Xian..

State Intellectual Property Office of China Releases The Second Xiangya Hospital of Central South University Patent Application for Application of Liraglutide in Preparation of Med..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has released The Second Xiangya Hospital of Central South University patent application for Application of Liraglutide in Preparation of Medicine for Treating Diffuse Alveolar Hemorrhage and Treatment Medicine. This invention was developed by Long Hai, He Liting and ..

State Intellectual Property Office of China Receives Sanya Central Hospital Hainan Third People's Hospital Sanya Central Hospital Sanya Central Hospital Patent Application for Nurs..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has received Sanya Central Hospital Hainan Third People's Hospital Sanya Central Hospital Sanya Central Hospital patent application for Nursing Medicine Composition for Preventing Pressure Sores and Preparation Method Thereof. Yang Juan, Wang Yingju and Wang Renxian ..

Heilongjiang University of Chinese Medicine Submits Chinese Patent Application for Traditional Chinese Medicine Tincture for Treating Alopecia Seborrhoeica as Well as Preparation M..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Heilongjiang University of Chinese Medicine has submitted a patent application for Traditional Chinese Medicine Tincture for Treating Alopecia Seborrhoeica as Well as Preparation Method and Application of Traditional Chinese Medicine Tincture. This invention was developed by Zhang Hailong and Cui Xiaoqian. Th..

China Academy of Chinese Medical Sciences Guang'anmen Hospital Seeks Patent for Liver-protecting Traditional Chinese Medicine Composition and Preparation Method Thereof

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- China Academy of Chinese Medical Sciences Guang'anmen Hospital has sought patent for Liver-protecting Traditional Chinese Medicine Composition and Preparation Method Thereof. This invention was developed by Shi Shuai, Hu Yuanhui, Zhang Zhenpeng, Cao Linlin, Wu Huaqin, Wang Huan and Sun Di. The patent applicat..

Tianjin University of Traditional Chinese Medicine Seeks Patent for Tabletting Candy Taking Gastrodia Elata as Monarch Drug for Strengthening Body Resistance and Resisting Aging an..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Tianjin University of Traditional Chinese Medicine has sought patent for Tabletting Candy Taking Gastrodia Elata as Monarch Drug for Strengthening Body Resistance and Resisting Aging and Preparation Method of Tablet Candy. This invention was developed by Gao Xiumei, Song Xinbo, Ding Hui, Pu Weiling and Liang L..

State Intellectual Property Office of China Publishes Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Patent Application for Traditional Chinese Medicine..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- State Intellectual Property Office of China has published Peking Union Medical College Hospital, Chinese Academy of Medical Sciences patent application for Traditional Chinese Medicine Composition for Improving Hypomenorrhea and Application Thereof. The invention was developed by Sun Aijun. The patent applica..

Chengdu University of Traditional Chinese Medicine Affiliated Hospital Sichuan Provincial Hospital of Trade Seeks Patent for Pharmaceutical Composition for Treating Chronic Kidney ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Chengdu University of Traditional Chinese Medicine Affiliated Hospital Sichuan Provincial Hospital of Trade has sought patent for Pharmaceutical Composition for Treating Chronic Kidney Disease Stage 1-3 as Well as Preparation Method and Application of Pharmaceutical Composition. This invention was developed by..

China Pharmaceutical University Submits Chinese Patent Application for Preparation Method of Forest Musk Deer Excrement-derived Anti-inflammatory and Analgesic Extract

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- China Pharmaceutical University has submitted a patent application for Preparation Method of Forest Musk Deer Excrement-derived Anti-inflammatory and Analgesic Extract. This invention was developed by Xie Guoyong, Ye Yucen, Qin Minjian, Dai Wenling, Wang Gang and Shang Jing. The patent application number is C..

Shanghai University of Traditional Chinese Medicine Submits Chinese Patent Application for Synergistic Anti-tumor Pharmaceutical Composition

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Shanghai University of Traditional Chinese Medicine has submitted a patent application for Synergistic Anti-tumor Pharmaceutical Composition. This invention was developed by Zhou Qianmei, Zhang Luyao, Shi Rong, Zhang Yifei and Yang Ziyi. The patent application number is CN20261055802 20260115. The patent publ..

Shionogi Submits Patent Application for Method and Pharmaceutical Composition for Treating Parkinson's Syndrome or Parkinson's Disease

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- Shionogi has submitted a patent application for Method and Pharmaceutical Composition for Treating Parkinson's Syndrome or Parkinson's Disease. Yamakawa Hidekuni and Yin Lini developed the invention. The patent application number is CN20241195499 20240809. The patent publication number is CN121534059 (A). Int..

North China University of Science and Technology Submits Chinese Patent Application for Application of AVE0991 in Preparation of New Target Medicine for Preventing and/or Treating ..

Pharmaceutical

| Mon 08 Jun 2026

Beijing, June 8 -- North China University of Science and Technology has submitted a patent application for Application of AVE0991 in Preparation of New Target Medicine for Preventing and/or Treating Hypertensive Kidney Injury. This invention was developed by Yang Xiuhong and Fang Fang. The patent application number is CN20261..

1 to 100 of 1493 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles